002622 皓宸医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-5.276-35.714-9.073-18.774-35.874
总资产报酬率 ROA (%)-1.043-8.364-2.485-5.951-14.984
投入资产回报率 ROIC (%)-1.675-12.881-3.585-8.009-17.473

边际利润分析
销售毛利率 (%)52.23344.58948.32650.89941.487
营业利润率 (%)-0.624-15.8740.433-5.740-14.788
息税前利润/营业总收入 (%)5.111-12.1534.225-1.033-45.085
净利润/营业总收入 (%)-1.702-18.484-1.769-7.699-55.971

收益指标分析
经营活动净收益/利润总额(%)236.15850.428-51.884-44.85847.062
价值变动净收益/利润总额(%)-6.7740.85539.887-34.913-26.551
营业外收支净额/利润总额(%)18.73111.387140.14319.72774.465

偿债能力分析
流动比率 (X)0.2890.2900.3340.3400.359
速动比率 (X)0.2400.2440.2770.2700.297
资产负债率 (%)76.69277.05470.41469.71565.223
带息债务/全部投入资本 (%)52.30951.19743.88344.15243.054
股东权益/带息债务 (%)60.23962.45690.02689.483105.441
股东权益/负债合计 (%)25.54225.87237.74940.41953.673
利息保障倍数 (X)0.869-2.1100.797-0.169-3.514

营运能力分析
应收账款周转天数 (天)12.29316.39214.81713.83726.477
存货周转天数 (天)51.11242.68145.64556.12264.237